Excellent thematic alignment: the venture sits precisely at the intersection of healthtech and pharma R&D that DayOne targets. Pre-seed stage and international scope match. However, score capped at 4 due to lack of detail on incorporation requirements (venture not yet incorporated), specific geographic prioritization, and funding size—factors that could affect eligibility. Recommend confirming these details before application.